TGF Beta FirePlex^®-HT Panel

TGF Beta FirePlex®-HT Panel (ab270739) uses FirePlex® particle technology to detect TGF-B1, TGF-B2, and TGF-B3 from 6.25 µl of sample input in 384-well plate format.

Assays are validated in serum, plasma, and cell culture supernatant, and can be run with 175 samples in duplicate per 384-well plate.

The two-step workflow and no-wash assay format limit hands-on time and are amenable to automation, thus making FirePlex-HT ideally suited for high-throughput screening studies. Assay readout is conducted on high-content imagers with data analysis using the FirePlex® Analysis Workbench software.

Users should note that assay performance data supplied in the accompanying Product Datasheet is a representative dataset, and is not lot-specific. For lot-specific assay performance data, please refer to the product"s certificate of analysis, which can be foundhere.

FirePlex® is a registered trade mark in certain territories (including Europe and the United States) and is an unregistered trade mark elsewhere.

• Cardiovascular
• Angiogenesis
• Growth Factors
• TGF

• Signal Transduction
• Growth Factors/Hormones
• TGF

• Stem Cells
• Signaling Pathways
• TGF beta
• Secreted

• Cancer
• Growth factors
• TGF

• Cancer
• Invasion/microenvironment
• Angiogenesis
• Angiogenic growth factors

• Cancer
• Cancer Metabolism
• Response to hypoxia

• Metabolism
• Pathways and Processes
• Cofactors, Vitamins / minerals
• Co-factors

• Metabolism
• Pathways and Processes
• Metabolism processes
• Hypoxia